Is EBP 883 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use EBP 883? Is EBP 883 safe for nursing mother and child? Does EBP 883 extracts into breast milk? Does EBP 883 has any long term or short term side effects on infants? Can EBP 883 influence milk supply or can EBP 883 decrease milk supply in lactating mothers?

Usually used alone or in combination with sofosbuvir in the treatment of hepatitis C. Since the last update we have not found published data on its excretion in breast milk. Its pharmacokinetic data (high molecular weight and very high percentage of plasma protein binding) make it very unlikely that significant amounts will pass into breast milk, so that, although there is disagreement (Thompson 2016), some authors consider that treatment with EBP 883, alone or in combination with sofosbuvir is not contraindicated during breastfeeding (Spera 2016, LactMed 2016). See below the information of these related products:

EBP 883 has not been studied in nursing mothers being treated for hepatitis C infection. Because it is 99% bound to maternal plasma proteins, amounts in breastmilk are likely to be very low. If EBP 883 used alone or in combination with sofosbuvir is required by the mother, it is not a reason to discontinue breastfeeding.[1] Some sources recommend against breastfeeding when EBP 883 is used with ribavirin. Hepatitis C is not transmitted through breastmilk[2][3] and breastmilk has been shown to inactivate hepatitis C virus (HCV).[4][5] However, the Centers for Disease Control recommends that mothers with HCV infection should consider abstaining from breastfeeding if their nipples are cracked or bleeding. It is not clear if this warning would apply to mothers who are being treated for hepatitis C. Infants born to mothers with HCV infection should be tested for HCV infection; because maternal antibody is present for the first 18 months of life and before the infant mounts an immunologic response, nucleic acid testing is recommended.[2][3]